Allevi, Inc is a Philadelphia-based company that specializes in 3D bioprinting technology. Their innovative bioprinters, materials, and reagents allow researchers to bring their work to life by creating custom 3D tissues for research, disease modeling, and regenerative medicine. With a range of bioprinters to choose from, Allevi offers versatility and precision in printing various bioinks and cell lines, making it possible to create any geometry for any application. Their patented Core Printheads ensure high viability across a wide range of bioinks, while smart calibration and a print bed designed to fit different printing dishes streamline the bioprinting workflow. Allevi's mission is to simplify and revolutionize the field of bioprinting, enabling researchers to explore new possibilities in tissue engineering, drug discovery, and clinical research.
With a focus on advancing the field of bioprinting, Allevi provides comprehensive solutions for various bioprinting applications. Their technology allows for the creation of organ-on-a-chip microfluidic devices, tissue engineering systems, and 3D disease models, accelerating research in regenerative medicine, cancer biology, and vaccine development. The company's bioprinters are designed for sterility and ease of use, with portable and easy-to-sterilize features. Precision and control are key features of Allevi's bioprinters, allowing researchers to print into well-plates and seed cells with single micron movements. With the ability to print with a wide range of viscosities, from soft hydrogels to thermoplastics, Allevi empowers researchers to explore new frontiers in bioprinting and reshape the future of healthcare.
Generated from the website